Wellington Management Group’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $971K | Sell |
228,021
-1,245,658
| -85% | -$5.31M | ﹤0.01% | 1720 |
|
|
2025
Q1 | $5.54M | Sell |
1,473,679
-51,805
| -3% | -$195K | ﹤0.01% | 1351 |
|
|
2024
Q4 | $8.84M | Buy |
1,525,484
+522,799
| +52% | +$3.03M | ﹤0.01% | 1226 |
|
|
2024
Q3 | $12M | Buy |
1,002,685
+97,428
| +11% | +$1.16M | ﹤0.01% | 1116 |
|
|
2024
Q2 | $9.79M | Buy |
905,257
+69,644
| +8% | +$754K | ﹤0.01% | 1156 |
|
|
2024
Q1 | $9.46M | Buy |
835,613
+736,200
| +741% | +$8.33M | ﹤0.01% | 1153 |
|
|
2023
Q4 | $1.39M | Buy |
99,413
+292
| +0.3% | +$4.1K | ﹤0.01% | 1561 |
|
|
2023
Q3 | $1.22M | Buy |
99,121
+38,011
| +62% | +$469K | ﹤0.01% | 1574 |
|
|
2023
Q2 | $552K | Buy |
+61,110
| New | +$552K | ﹤0.01% | 1677 |
|
|
2022
Q3 | – | Sell |
-275,984
| Closed | -$1.12M | – | 2117 |
|
|
2022
Q2 | $1.12M | Sell |
275,984
-712,055
| -72% | -$2.9M | ﹤0.01% | 1658 |
|
|
2022
Q1 | $4.21M | Sell |
988,039
-1,031,070
| -51% | -$4.39M | ﹤0.01% | 1434 |
|
|
2021
Q4 | $18.9M | Buy |
2,019,109
+369,905
| +22% | +$3.46M | ﹤0.01% | 1093 |
|
|
2021
Q3 | $45.5M | Buy |
1,649,204
+32,906
| +2% | +$907K | 0.01% | 841 |
|
|
2021
Q2 | $45.2M | Sell |
1,616,298
-398,917
| -20% | -$11.2M | 0.01% | 854 |
|
|
2021
Q1 | $66.1M | Sell |
2,015,215
-54,100
| -3% | -$1.78M | 0.01% | 730 |
|
|
2020
Q4 | $96.4M | Buy |
+2,069,315
| New | +$96.4M | 0.02% | 600 |
|